Literature DB >> 29264671

Hypothyroidism and Wound Healing After Salvage Laryngectomy.

Andrew J Rosko1, Andrew C Birkeland1, Emily Bellile2, Kevin J Kovatch1, Ashley L Miller3, Craig C Jaffe4, Andrew G Shuman1, Steven B Chinn1, Chaz L Stucken1, Kelly M Malloy1, Jeffrey S Moyer1, Keith A Casper1, Mark E P Prince1, Carol R Bradford1, Gregory T Wolf1, Douglas B Chepeha5, Matthew E Spector6.   

Abstract

BACKGROUND: Patients undergoing salvage laryngectomy are predisposed to radiation-induced hypothyroidism and impaired wound healing secondary to the tissue effects of prior treatment. The impact of hypothyroidism on postoperative wound healing is not established.
METHODS: A single-institution retrospective case series was performed. The inclusion criteria specified preoperatively euthyroid adults who underwent salvage laryngectomy with concurrent neck dissection between 1997 and 2015 for persistent or recurrent laryngeal squamous cell carcinoma after radiation or chemoradiation therapy (n = 182). The principal explanatory variable was postoperative hypothyroidism, defined as thyroid-stimulating hormone (TSH) higher than 5.5 mIU/L. The primary end points of the study were pharyngocutaneous fistulas and wounds requiring reoperation. Multivariate analysis was performed.
RESULTS: The fistula rate was 47% among hypothyroid patients versus 23% among euthyroid patients. In the multivariate analysis, the patients who experienced hypothyroidism in the postoperative period had a 3.6-fold greater risk of fistula [95% confidence interval (CI) 1.8-7.1; p = 0.0002]. The hypothyroid patients had an 11.4-fold greater risk for a required reoperation (24.4 vs 5.4%) than the euthyroid patients (95% CI 2.6-49.9; p = 0.001). The risk for fistula (p = 0.003) and reoperation (p = 0.001) increased with increasing TSH. This corresponds to an approximate 12.5% incremental increase in the absolute risk for fistula and a 10% increase in the absolute risk for reoperation with each doubling of the TSH.
CONCLUSION: Postoperative hypothyroidism independently predicts postoperative wound-healing complications. The association of hypothyroidism with fistula formation may yield opportunities to modulate wound healing with thyroid supplementation or to provide a biomarker of wound progression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29264671      PMCID: PMC6002868          DOI: 10.1245/s10434-017-6278-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  52 in total

1.  Microvascular surgery in the previously operated and irradiated neck.

Authors:  Matthew M Hanasono; Yoav Barnea; Roman J Skoracki
Journal:  Microsurgery       Date:  2009       Impact factor: 2.425

2.  Prevention of wound complications following salvage laryngectomy using free vascularized tissue.

Authors:  Kevin Fung; Theodoros N Teknos; Curtis D Vandenberg; Teresa H Lyden; Carol R Bradford; Norman D Hogikyan; Jennifer Kim; Mark E P Prince; Gregory T Wolf; Douglas B Chepeha
Journal:  Head Neck       Date:  2007-05       Impact factor: 3.147

Review 3.  Pharyngocutaneous fistula after total laryngectomy: systematic review of risk factors.

Authors:  Rogério Aparecido Dedivitis; Felipe Toyama Aires; Claudio Roberto Cernea; Lenine Garcia Brandão
Journal:  Head Neck       Date:  2015-06-26       Impact factor: 3.147

4.  Laparoscopic harvest of the jejunal free flap for reconstruction of hypopharyngeal and cervical esophageal defects.

Authors:  J Trad Wadsworth; Neal Futran; Thomas R Eubanks
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-12

5.  Risk factors associated with hypothyroidism after laryngectomy.

Authors:  R L Gal; T J Gal; D W Klotch; A B Cantor
Journal:  Otolaryngol Head Neck Surg       Date:  2000-09       Impact factor: 3.497

6.  Extent of thyroid resection and thyroid function after postoperative radiotherapy following total laryngectomy or total pharyngo-laryngo-esophagectomy.

Authors:  Rio Kojima; Kiyoaki Tsukahara; Ray Motohashi; Takuro Okada; Masanori Yatomi; Yasuaki Katsube; Atsuo Takeda; Ayumi Agata; Yasuo Ogawa
Journal:  Int J Clin Oncol       Date:  2017-01-04       Impact factor: 3.402

Review 7.  Systematic review and meta-analysis of the complications of salvage total laryngectomy.

Authors:  Z Hasan; R C Dwivedi; D A Gunaratne; S A Virk; C E Palme; F Riffat
Journal:  Eur J Surg Oncol       Date:  2016-05-27       Impact factor: 4.424

8.  Surgery after organ preservation therapy. Analysis of wound complications.

Authors:  A M Sassler; R M Esclamado; G T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-02

9.  Primary and central hypothyroidism after radiotherapy for head-and-neck tumors.

Authors:  Niranjan Bhandare; Laurence Kennedy; Robert S Malyapa; Christopher G Morris; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-18       Impact factor: 7.038

10.  Closure of post-laryngectomy pharyngocutaneous fistulae.

Authors:  Isaac A Bohannon; William R Carroll; J Scott Magnuson; Eben L Rosenthal
Journal:  Head Neck Oncol       Date:  2011-05-26
View more
  4 in total

1.  ASO Author Reflections: Hypothyroidism and Wound Healing After Salvage Laryngectomy.

Authors:  Andrew J Rosko; Matthew E Spector
Journal:  Ann Surg Oncol       Date:  2018-10-15       Impact factor: 5.344

2.  Association of Bolster Duration With Uptake Rates of Fibula Donor Site Skin Grafts.

Authors:  Abel P David; Chase Heaton; Andrea Park; Rahul Seth; P Daniel Knott; Jeffrey D Markey
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-06-01       Impact factor: 6.223

Review 3.  Thyroid Hormone Signalling in Human Evolution and Disease: A Novel Hypothesis.

Authors:  Polyxeni Mantzouratou; Angelo Michele Lavecchia; Christodoulos Xinaris
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

4.  The Effect of Hypothyroidism on Surgical Outcomes Postabdominoplasty: A Case-control Study.

Authors:  Rawan ElAbd; Becher Alhallabi; Salman AlSabah; Hisham Burezq
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.